← Back to Search
Epidemiology Of Malignant Mesothelioma In Australia.
A. Musk, N. de Klerk
Published 2004 · Medicine
Download PDFAnalyze on Scholarcy
In Australia, consumption of asbestos peaked in about 1975 at around 70,000t per year--the majority being used for asbestos cement manufacture. Chrysotile, amphibole and crocidolite have all been mined in Australia and employment records from the single company which mined most of the crocidolite deposits at Wittenoom have formed the basis of an ongoing cohort mortality study of the workforce.
This paper references
Wittenoom, Western Australia: a modern industrial disaster.
A. Musk (1992)
Trends in mortality from malignant mesothelioma of the pleura, and production and use of asbestos in Australia
Z. Xu (1985)
Epidemiology of Mesothelioma
N. Klerk (2002)
Enviromental exposure to crocidolite and mesothelioma: Exposure-response relationships
J. Hansen (1995)
The incidence of malignant mesothelioma in Australia, 1947‐1980
A. Musk (1989)
Diseases in miners and millers of crocidolite from Wittenoom, Western Australia: a further follow-up to December 1986
N. Klerk (1994)
Predictions of future cases of asbestos‐related disease among former miners and millers of crocidolite in Western Australia
Nicholas H. de Klerk (1989)
Malignant mesothelioma in Pilbara Aborigines.
A. Musk (1995)
Epidemiology of malignant mesothelioma in Western Australia.
B. Armstrong (1984)
Dose response relationships and predictions for mesothelioma in subjects exposed to crocidolite at Wittenoom, Western Australia
A. Musk (1993)
This paper is referenced by
Peritoneal mesothelioma: current understanding and management
T. Chua (2009)
Management of malignant pleural mesothelioma.
S. West (2006)
Predicted mortality from malignant mesothelioma among women exposed to blue asbestos at Wittenoom, Western Australia
A. Reid (2008)
Mesothelioma risk after 40 years since first exposure to asbestos: a pooled analysis
A. Reid (2014)
Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesothelioma.
A. Powell (2006)
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma.
C. Robinson (2011)
Optimising the use of indwelling pleural catheter in the management of malignant pleural effusion
Rajesh Thomas (2017)
Malignant pleural mesothelioma : novel biomarkers and related pathways
Filip Mundt (2013)
Pathogenesis of malignant pleural mesothelioma
M. Jaurand (2005)
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
O. D. Røe (2015)
Wnt7A is a putative prognostic and chemosensitivity marker in human malignant pleural mesothelioma
T. Hirata (2015)
Detection of malignant mesothelioma in asbestos-exposed individuals: the potential role of soluble mesothelin-related protein.
J. Creaney (2005)
Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution
A. Bece (2015)
Sistemazione and death: the role of the Wittenoom asbestos mine in the lives and deaths of Italian transnational workers
A. D. Pasquale (2013)
Development of a Job-Exposure Matrix (AsbJEM) to Estimate Occupational Exposure to Asbestos in Australia.
Svein C van Oyen (2015)
Cancer incidence among women and girls environmentally and occupationally exposed to blue asbestos at Wittenoom, Western Australia
A. Reid (2008)
Dusted Community: Piloting a Virtual Peer-to-Peer Support Community for People with an Asbestos-Related Diagnosis and Their Families
D. Kozlowski (2014)
Body composition analysis in the assessment of cancer cachexia treatment outcomes.
A. Aslani (2008)
Mesothelin and kidney function--analysis of relationship and implications for mesothelioma screening.
N. Boudville (2011)
The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma
H. Nelson (2011)
Variations in mesothelioma mortality rates among migrants to Australia and Australian-born
S. Si (2018)
Pleural mesothelioma: little evidence, still time to do trials
T. Treasure (2004)
Audit of patients with mesothelioma treated with pemetrexed in a single institution in Western Australia
A. Hasani (2010)
Lung cancer: Biology and treatment options.
H. Lemjabbar-Alaoui (2015)
Mutational Analysis of Hedgehog Signaling Pathway Genes in Human Malignant Mesothelioma
C. Lim (2013)
SYNDECAN-1 INSIGHTS IN MESOTHELIOMA THESIS FOR DOCTORAL DEGREE ( Ph . D . ) By Ghazal
Heidari Hamedani (2017)
Impact of Tumor Angiogenesis in Peritoneal Mesothelioma After Radical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
T. Chua (2009)
Serum and pleural fluid biomarkers for mesothelioma
J. Creaney (2009)
Gene therapy of mesothelioma
D. Nelson (2005)
Pleural Fluid Mesothelin as an Adjunct to the Diagnosis of Pleural Malignant Mesothelioma
J. Creaney (2014)
S. Kao (2010)
A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
C. Hooper (2012)See more